Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global soft gelatin capsules market size was valued at USD 3.98 billion in 2024. The market is projected to grow from USD 4.18 billion in 2025 to USD 5.63 billion by 2031, exhibiting a CAGR of 5.2% during the forecast period.
Soft gelatin capsules, commonly known as softgels, are oral dosage forms consisting of a single-piece, hermetically sealed shell surrounding a liquid or semi-solid matrix. The shell is typically composed of gelatin, plasticizers, and water, which encases the active pharmaceutical ingredient (API) or nutraceutical compound, offering advantages like improved bioavailability, taste masking, and precise dosing. Furthermore, this dosage form is highly suitable for filling with oils, suspensions, and other challenging formulations.
The market growth is primarily driven by the expanding pharmaceutical and nutraceutical sectors. The health supplements segment holds the largest application share, accounting for over 50% of the market, propelled by rising consumer health consciousness and demand for products like omega-3 fatty acids and fat-soluble vitamins. While gelatin-type capsules currently dominate with over 85% market share, there is a notable rise in demand for non-animal alternatives derived from materials like starch or HPMC. Geographically, the Asia-Pacific region leads the market, contributing over 30% of global sales, followed by Europe, reflecting strong manufacturing bases and growing consumer markets.
Rising Consumer Preference for Easy-to-Swallow Dosage Forms
The global soft gelatin capsules market is experiencing significant growth, primarily driven by the increasing consumer inclination towards easy-to-ingest pharmaceutical and nutraceutical products. Softgels are particularly favored by pediatric and geriatric populations, as well as individuals with pill-swallowing difficulties, due to their smooth, slippery coating and lack of taste or odor. This enhanced patient compliance is a critical factor for pharmaceutical companies when developing new formulations.
Expanding Nutraceutical and Cosmeceutical Industries
The booming nutraceutical sector, encompassing vitamins, minerals, and dietary supplements, is a major contributor to market expansion. Soft gelatin capsules are an ideal delivery system for oil-based formulations, such as fish oil and vitamin E, providing superior bioavailability and protection from oxidation. The cosmeceutical industry also leverages softgels for skin-benefiting ingredients like collagen and ceramides, further propelling demand.
➤ The global softgel capsule market was valued at approximately $5.8 billion in 2023 and is projected to grow at a CAGR of around 6.5% over the next five years.
Furthermore, advancements in manufacturing technologies have enabled the production of specialized softgels, including enteric-coated, sustained-release, and two-piece capsules for incompatible ingredients. This technological innovation allows for more complex and effective drug formulations, meeting the evolving needs of modern therapeutics.
MARKET CHALLENGES
High Manufacturing Costs and Complex Production Process
The production of soft gelatin capsules is a complex and capital-intensive process compared to other solid dosage forms. It requires specialized equipment, stringent control over temperature and humidity, and high-quality raw materials like gelatin, plasticizers, and opacifiers. Fluctuations in the price and supply of these raw materials, particularly high-grade gelatin, can significantly impact production costs and profit margins for manufacturers.
Other Challenges
Regulatory Hurdles and Quality Control
Stringent regulatory requirements from agencies like the FDA and EMA mandate rigorous testing for stability, dissolution, and bioavailability. Ensuring batch-to-batch consistency and preventing issues like cross-linking of gelatin, which affects dissolution, requires sophisticated quality control systems, adding to operational complexity and cost.
Competition from Alternative Delivery Systems
Softgels face increasing competition from newer and sometimes cheaper dosage forms, such as gummies in the nutraceutical space and orally disintegrating tablets (ODTs) in pharmaceuticals. These alternatives also offer ease of administration and can challenge the market share of soft gelatin capsules, especially in consumer health segments.
Shifting Preferences for Vegetarian and Vegan Alternatives
A significant restraint for the traditional soft gelatin capsule market is the growing consumer demand for vegetarian and vegan products. Conventional softgels are primarily made from animal-derived gelatin (bovine or porcine), which is unsuitable for these demographics. While plant-based alternatives like starch and pullulan exist, they often come with technical challenges related to barrier properties and manufacturing processes, limiting their widespread adoption and creating a barrier to market growth in certain regions.
Limited Suitability for Hydrophilic Formulations
Soft gelatin capsules are predominantly designed for encapsulating lipophilic (oil-based) liquids, suspensions, or pastes. They are generally unsuitable for highly hydrophilic (water-based) active ingredients, which can migrate into the shell and cause stability issues or brittle capsules. This inherent limitation restricts the application of softgels for a wide range of pharmaceutical compounds, funneling development efforts towards other dosage forms.
Development of Non-Gelatin and Specialty Capsules
The rising demand for halal, kosher, and vegetarian-certified products presents a substantial opportunity for innovation. Investing in the development and commercialization of high-quality non-animal softgel shells, such as those based on fish gelatin, modified starch, or hydrocolloid blends, can unlock new consumer markets and applications. These specialty capsules can command premium pricing and align with evolving ethical and dietary trends.
Expansion in Emerging Economies
Emerging economies in Asia-Pacific and Latin America represent significant growth frontiers. Rising disposable incomes, increasing health awareness, and improving healthcare infrastructure are driving the demand for pharmaceuticals and dietary supplements. Local manufacturing partnerships and targeted marketing strategies in these regions can help companies capture a larger share of the growing middle-class population, which is increasingly adopting preventive healthcare measures.
Innovation in Drug Delivery
There is a considerable opportunity to leverage softgel technology for advanced drug delivery systems. This includes developing capsules for poorly soluble drugs using lipid-based formulations to enhance bioavailability, creating fixed-dose combinations, and engineering targeted release profiles. Collaborations between softgel manufacturers and pharmaceutical R&D departments can lead to the creation of high-value, patented products with improved therapeutic outcomes.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Gelatin Type is the dominant segment, benefiting from its long-established manufacturing processes, excellent barrier properties, and widespread consumer familiarity. These capsules offer superior stability for a wide range of active ingredients, particularly oils and lipophilic substances. The Non-animal Type segment, including plant-based polymers, is experiencing significant growth driven by increasing consumer demand for vegetarian and vegan products, as well as addressing religious and cultural preferences. However, technical challenges related to oxygen permeability and ensuring comparable dissolution profiles to traditional gelatin capsules remain key focus areas for innovation and development in this emerging segment. |
| By Application |
|
Health Supplements represent the leading application segment, driven by the global trend towards preventative healthcare and self-medication. Softgels are ideally suited for delivering oil-based nutrients like Omega-3 fatty acids, vitamins A, D, and E, and various herbal extracts due to their ability to encapsulate liquids and improve bioavailability. The Pharmaceutical sector remains a critical and high-value segment, utilizing softgels for their precise dosing, taste-masking capabilities, and improved patient compliance compared to other oral dosage forms. The "Others" category includes niche applications in cosmeceuticals and other specialized fields, where the aesthetic appeal and encapsulation efficiency of softgels are increasingly valued. |
| By End User |
|
Contract Manufacturing Organizations (CMOs) are pivotal end users, as many pharmaceutical and nutraceutical companies outsource softgel production to leverage specialized expertise, advanced technologies, and cost-effective manufacturing scales. These organizations drive innovation and cater to a diverse client base. In-house Pharmaceutical Companies typically utilize softgels for high-volume, proprietary drugs where maintaining control over the entire production process is critical for quality and regulatory compliance. Nutraceutical & Supplement Brands represent a highly dynamic segment, often relying on CMOs but increasingly investing in product differentiation through specialized formulations and unique delivery systems to capture consumer attention in a crowded marketplace. |
| By Shell Characteristics |
|
Standard Softgels are the workhorse of the market, used for the vast majority of applications where rapid dissolution in the stomach is desired. Enteric-coated Softgels are a significant growth area, designed to resist stomach acid and disintegrate in the intestine, thereby protecting acid-sensitive active ingredients and reducing gastric irritation. This is particularly important for certain pharmaceutical compounds and probiotics. The development of Specialty Formulations, such as soluble or chewable softgels, caters to specific patient populations like pediatrics and geriatrics, enhancing compliance and expanding the potential applications for softgel technology beyond traditional uses. |
| By Therapeutic Area |
|
General Wellness & Immunity is the dominant therapeutic area, heavily driven by the health supplements segment and encompassing multivitamins, mineral supplements, and herbal products aimed at maintaining overall health. Cardiovascular Health is a major segment, with softgels being the preferred delivery system for high-dose fish oil and CoQ10 supplements due to their efficient encapsulation of oils. Bone & Joint Health applications are significant, utilizing softgels for fat-soluble vitamins like Vitamin D and various anti-inflammatory ingredients. The versatility of softgels in handling complex formulations makes them suitable for a broadening range of therapeutic targets, responding to evolving consumer health trends. |
A Highly Consolidated Market Led by Global CDMOs and Health Brands
The global Soft Gelatin Capsules market is characterized by a significant level of consolidation, with the top five manufacturers collectively holding a sales market share exceeding 40%. Catalent, Inc. is a dominant force in this space, leveraging its extensive contract development and manufacturing organization (CDMO) capabilities and global footprint. Similarly, Aenova Group and Patheon (now part of Thermo Fisher Scientific) are other major CDMO players with substantial manufacturing capacity and technological expertise, serving a diverse clientele in the pharmaceutical and nutraceutical sectors. This concentration of market share among a few large players is driven by the high capital investment required for manufacturing facilities, stringent regulatory compliance, and the need for sophisticated R&D to develop specialized formulations.
Beyond the market leaders, a number of other significant players compete by carving out specific niches or focusing on regional strengths. Companies like Procaps from Colombia and Sirio Pharma from China have established strong positions in their respective geographic markets. Strides Pharma Science brings significant scale from India, while specialty manufacturers like Soft Gel Technologies focus on high-potency active ingredients and complex formulations. A notable trend is the strong presence of vertically integrated consumer health brands such as Nature’s Bounty and Amway, which manufacture a substantial portion of their own softgel supplements, thereby controlling quality and supply chain from ingredient to finished product. The Asia-Pacific region is a particularly dynamic and competitive area, accounting for over 30% of the sales market share, with numerous local manufacturers like Baihe Biotech and Ziguang Group competing effectively.
List of Key Soft Gelatin Capsules Companies ProfiledCatalent
Nature’s Bounty
Patheon (Thermo Fisher Scientific)
Aland (Jiangsu) Nutraceutical Co., Ltd.
EuroCaps Ltd.
Captek Softgel International
Strides Pharma Science
Soft Gel Technologies, Inc.
Amway
Sirio Pharma Co., Ltd.
Baihe Biotech Co., Ltd.
Ziguang Group
The global soft gelatin capsules market is on a significant growth trajectory, with its valuation projected to rise from US$ 3978 million in 2024 to US$ 5625 million by 2031, representing a compound annual growth rate (CAGR) of 5.2%. This sustained expansion is largely fueled by their extensive application in the health supplements sector. Softgels offer superior consumer benefits, including ease of swallowing, improved bioavailability of active ingredients, and effective masking of unpleasant tastes and odors, making them a preferred dosage form for vitamins, minerals, and omega-3 fatty acids. The largest application segment for softgels is health supplements, which holds a dominant position in the market.
Other TrendsDominance of Gelatin and Regional Market Leadership
Gelatin-based softgel capsules continue to command the market with an overwhelming sales share exceeding 85%. This dominance is attributed to their well-established manufacturing processes and excellent encapsulation properties. From a geographical perspective, the Asia-Pacific region has emerged as the market leader, accounting for over 30% of global sales. This is closely followed by Europe, indicating a strong and established market presence in these regions. The concentration of manufacturing capabilities and rising consumer health awareness in Asia-Pacific are key factors underpinning its leading position.
The competitive environment is characterized by a high degree of consolidation, with the top five manufacturers collectively holding a sales market share of over 40%. Key global players include Catalent, Aenova, Nature’s Bounty, Procaps, and Patheon (Thermo Fisher Scientific). These companies actively engage in strategic initiatives such as mergers, acquisitions, and the development of innovative manufacturing technologies to enhance their market position. The competitive strategies focus on expanding production capacity, improving efficiency, and developing specialized formulations to cater to the evolving demands of the pharmaceutical and nutraceutical industries.
Regional Analysis: Soft Gelatin Capsules MarketEurope
Europe represents a highly significant and well-established market for soft gelatin capsules, characterized by a strong pharmaceutical sector and a growing nutraceutical industry. Countries like Germany, France, and the United Kingdom are key contributors, with a focus on quality manufacturing and innovative drug delivery systems. The region's market is driven by an aging population with increasing health concerns and a cultural predisposition towards preventive healthcare, boosting demand for vitamins and prescription drugs in softgel form. Strict regulatory standards set by the European Medicines Agency ensure product safety but also create a high barrier to entry. Sustainability concerns are also beginning to influence the market, with exploration into plant-based and other alternative shell materials gaining traction among manufacturers and consumers alike.
Asia-Pacific
The Asia-Pacific region is the fastest-growing market for soft gelatin capsules, propelled by expanding healthcare access, rising disposable incomes, and increasing health consciousness. Key growth engines include China and India, where large populations and growing domestic pharmaceutical industries are driving both production and consumption. The market is characterized by a rising demand for affordable generic medicines and dietary supplements. While the market is less mature than in the West, it offers immense potential for contract manufacturing due to lower production costs. However, the regulatory landscape is diverse and can be complex to navigate, presenting both challenges and opportunities for regional and international players looking to capitalize on this dynamic growth area.
South America
The soft gelatin capsules market in South America is emerging, with Brazil and Argentina being the primary markets. Growth is primarily fueled by an expanding middle class and improving healthcare infrastructure, leading to greater access to pharmaceutical products and dietary supplements. The market faces challenges, including economic volatility in some countries and less developed local manufacturing capabilities compared to global leaders, which can lead to reliance on imports. Nevertheless, there is growing local production focused on meeting regional demand for vitamins and essential medicines, indicating a market with steady, long-term growth potential as economic conditions stabilize and healthcare systems continue to develop.
Middle East & Africa
The Middle East and Africa region presents a developing market for soft gelatin capsules, with growth concentrated in more affluent Gulf Cooperation Council countries like Saudi Arabia and the UAE. The market is primarily import-dependent, with demand driven by a growing expatriate population, rising health awareness, and increasing government healthcare expenditure. In Africa, the market is very nascent, with South Africa showing the most promise. Challenges include fragmented distribution networks, regulatory hurdles, and price sensitivity. However, the region offers significant untapped potential, especially for essential medicines and basic vitamin supplements, as healthcare access continues to improve across the continent.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ <極端>Segmentation Analysis
By product type or category
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors极>
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global soft gelatin capsules market was valued at USD 3.98 billion in 2024 and is expected to reach USD 5.63 billion by 2031.
Which key companies operate in Global Soft Gelatin Capsules Market?
-> Key players include Catalent, Aenova, Nature�s Bounty, Procaps, Patheon (Thermo Fisher Scientific), among others.
-> Key growth drivers include expanding pharmaceutical and nutraceutical sectors, health consciousness, and demand for improved drug delivery forms.
-> Asia-Pacific is the leading region, followed by Europe, reflecting strong manufacturing bases and growing consumer markets.
-> Emerging trends include rise of non-animal alternatives, smart formulations, and sustainable encapsulation solutions.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates